The short version
- Why people research itLocal muscle repair and satellite-cell activation post-training.
- What the evidence isNo human trials: development stopped at preclinical, so the ceiling on any claim here is a rodent model — and these transfer poorly.
- What to watchHives, flushing or breathlessness soon after use, which fits a PEG reaction.
How PEG-MGF works
Splice variant of IGF-1 (IGF-1Ec) that activates muscle satellite cells for local repair; PEGylation extends its short native half-life.
The MGF page in this catalog already deals with the peptide: whether the free 24-residue E-domain exists in any animal Matheny 2010, and the receptor assays in which it activated nothing Janssen 2016 Fornaro 2014. This page is about the other half of the name.
What a PEG chain is, physically. Polyethylene glycol is a chain of repeating CH2CH2O units: flexible, uncharged, extremely water-loving polymer. Each ethylene oxide unit holds two to three water molecules, so a PEG chain in solution is not a compact lump — it is a hydrated random coil that sweeps out a large volume.
- Injectable
On the goal map: Satellite cells & local repair (Build muscle & strength)
Research on PEG-MGF4 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
No human trials: development stopped at preclinical, so the ceiling on any claim here is a rodent model — and these transfer poorly.
No completed human trial
Correlative data
Used in place of MGF specifically to solve the half-life problem. Reported experience is of a broader, more systemic effect than local MGF, which is what the modification predicts.
How the mechanism reads
MGF with a polyethylene glycol chain attached, extending serum half-life from minutes to hours.
MechanisticPEGylation solves the delivery problem and arguably defeats the point. MGF's proposed role is a local, transient signal at a site of mechanical damage; making it circulate for hours converts a local repair cue into a systemic one, and nobody has shown that the satellite-cell effect survives the change.
Mechanistic
Sources
- Zuma LK, et al. Protein PEGylation: Navigating Recombinant Protein Stability, Aggregation, and Bioactivity. BioMed Research International 2022 · PMID 35924267
- Wu W, et al. PEGylated Recombinant Human Growth Hormone Jintrolong Exhibits Good Long-Term Safety in Cynomolgus Monkeys and Human Pediatric Growth Hormone Deficiency Patients. Frontiers in Endocrinology 2022 · PMID 35909512
- Janssen JA, et al. Potency of Full-Length MGF to Induce Maximal Activation of the IGF-I R Is Similar to Recombinant Human IGF-I at High Equimolar Concentrations. PLoS One 2016 · PMID 26991004
- Fornaro M, et al. Mechano-growth factor peptide, the COOH terminus of unprocessed insulin-like growth factor 1, has no apparent effect on myoblasts or primary muscle stem cells. American Journal of Physiology: Endocrinology and Metabolism 2014 · PMID 24253050
- Matheny RW Jr, Nindl BC, Adamo ML. Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration. Endocrinology 2010 · PMID 20130113
- Hameed M, Orrell RW, Cobbold M, Goldspink G, Harridge SDR. Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. Journal of Physiology 2003 · PMID 12562960
PEG-MGF safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Cancer history or a suspected tumor: a longer-acting IGF-1 splice variant prolongs growth signaling.
- Allergy to PEG or prior reactions to PEGylated drugs: anti-PEG antibodies can cause hives or worse.
- Insulin use: IGF-1 pathway activity lowers glucose through shared receptors.
- Pregnancy: a long-lived growth factor has no gestational data.
- Under 18, with growth plates still open.
What’s expected
- Muscle fullness and soreness near where it is used, with the effect lasting far longer than plain MGF.
- Mild water retention while using PEG-MGF.
- Occasional tiredness as the pegylated molecule lingers.
Watch for
- Hives, flushing or breathlessness soon after use, which fits a PEG reaction.
- A hard lump or swelling at the muscle site.
- Finger numbness from fluid pressure.
- Shaky spells from low glucose.
Labs that tell you it’s working
- IGF-1 (Insulin-like Growth Factor 1)
- Insulin (Fasting)
- Complete Blood Count (CBC) w/ Differential
- Comprehensive Metabolic Panel (CMP)
PEG-MGF is IGF-1Ec with polyethylene glycol added, so IGF-1 growth effects last longer and PEG allergy becomes a risk.
Bloodwork to runHow you would know it is working: 6 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
PEG-MGF FAQ4 common questions
- Is PEG-MGF approved for human use?
- No. PEG-MGF is a research compound. No completed randomized human trial has given it yet.
- What is PEG-MGF researched for?
- Local muscle repair and satellite-cell activation post-training.
- Which labs show whether it's doing anything?
- IGF-1; Insulin; Complete Blood Count; Comprehensive Metabolic Panel: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for PEG-MGF: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.




